Authored By: Sarah
11 Jul 2024

 Hematology Analyzers and Reagents Market Size to grow by USD 3911.6 million between 2024-2028

According to a research report “ Hematology Analyzers and Reagents Market” by Product (Reagents and consumables, Instruments) End-user (Hospitals, Clinical laboratories, Research institute, Others) Geography (North America, Asia, Europe, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 3911.6 million, at a CAGR of  6.95% during the forecast period. In the realm of hematology analysis, fully automated solutions offer significant advantages for hospitals and clinical laboratories. By automating previously manual tasks, these systems provide cost-effective, precise results, saving valuable time and resources. Automation minimizes human error, thereby enhancing laboratory productivity and enabling researchers to focus on data analysis and interpretation. Additionally, the technology underpinning automated systems generates substantial data volumes at accelerated turnaround times, offering data-driven insights to optimize performance and streamline workflows. Continuous process monitoring and data collection further augment throughput and alleviate the burden on healthcare professionals.

Browse market data tables, figures, and in-depth TOC on “Hematology Analyzers and Reagents Market” by Product (Reagents and consumables, Instruments) End-user (Hospitals, Clinical laboratories, Research institute, Others) Geography (North America, Asia, Europe, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Product, the Reagents and consumables segment is projected to dominate the market size in 2024

The hospitals segment, a significant end-user in the global hematology analyzers and reagents market, is characterized by large tertiary care institutions, community hospitals, and specialized clinics. These healthcare facilities prioritize patient care and rely on advanced hematology analyzers to diagnose and manage blood-related disorders promptly and accurately. Equipped with sophisticated technology and expert teams, large tertiary care facilities often have specialized hematology departments. To maintain high-quality patient care and ensure reliable results, these institutions invest in premium hematology analyzers, which enable critical decision-making in a timely manner.

By End-user, Hospitals  segment is expected to hold the largest market size for the year 2024

In the global hematology analyzers and reagents market, hematology reagents play a pivotal role as they are specifically designed for use in automated cell counters to analyze the morphology and components of blood and blood-forming tissues. These reagents are indispensable consumables in the hematology system, functioning as substances or compounds that initiate chemical reactions during the analysis process. Regular replacement is necessary due to their exhaustion during use. Hematology analyzers rely on these dedicated reagents for accurate and efficient blood analysis.

North America is forecasted to hold the largest market size by region in 2024

The North American hematology analyzers and reagents market is experiencing robust growth, driven by substantial investments in healthcare research and testing in the United States. In 2020, the Centers for Medicare and Medicaid Services (CMS) reported a 2.7% increase in US national health expenditure to USD4.3 trillion, equating to USD12,914 per person and accounting for 18.3% of the country's gross domestic product. This significant spending on healthcare has fueled the demand for advanced hematology solutions, including analyzers and reagents. The well-established distribution networks in countries like the US and Canada, coupled with manufacturers' focus on offering comprehensive hematology solutions portfolios to hospitals and diagnostic centers, further bolsters the market expansion in the region.

The Hematology Analyzers and Reagents Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Bio Rad Laboratories Inc.
  • BioSystems SA
  • Boule Diagnostics AB
  • Danaher Corp.
  • EKF Diagnostics Holdings Plc
  • Erba Diagnostics FZ LLC
  • F. Hoffmann La Roche Ltd.
  • Heska Corp.
  • HORIBA Ltd.
  • Mindray Bio medical Electronics Co. Ltd.
  • NeoMedica
  • Nihon Kohden Corp.
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Toyobo Co. Ltd.
  • URIT Medical Electronic Co. Ltd.
  • Zoetis Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Hematology Analyzers and Reagents market is a significant segment of the healthcare sector, focusing on the measurement of various hematology parameters, including C-reactive protein (CRP), hemoglobin (Hb), hematocrit levels, and plasma protein concentrations. Automated hematology analyzers play a crucial role in this market, providing accurate and efficient analysis of these parameters, making them indispensable tools for diagnosing and monitoring blood disorders, such as anemia, leukemia, and lymphoma (including Blood Cancers). These analyzers are widely used in hospitals, diagnostic laboratories, blood banks, and research institutions. Immunohematology and coagulation analyzers are essential components of the hematology analyzer, enabling the detection of blood group antigens and coagulation factors, respectively. Moreover, flow cytometers and haemoglobin analyzers are also integral parts of the hematology analyzer system. The increasing demand for automation in healthcare and the growing number of blood donations are expected to drive the growth of the Hematology Analyzers and Reagents market. Additionally, advancements in technology are leading to the development of more sophisticated and versatile hematology analyzers, further expanding their applications in the diagnosis and management of various blood disorders and hemostasis conditions.

Market Research Overview

The Hematology Analyzers and Reagents market encompasses various instruments and consumables used in the diagnosis and analysis of hematology parameters. CBC tests, a crucial aspect of this market, provide essential information on hemoglobin (Hb), hematocrit levels, blood platelets, and other blood cells. Coagulation testing, another key application, aids in identifying infection-related conditions and hemorrhagic conditions. Biopharma companies and clinical laboratories, including hospitals, are significant end-users of these analyzers. Semi-automated hematology analyzers, point-of-care test instruments, and flow cytometry instrumentations are integral to this market. Reagent and consumables, including C-reactive protein (CRP) and immunohematology reagents, are essential for accurate testing. Safety, automation, and integration are critical factors driving market growth. Advancements in technology, such as Life Line Curves and magnifiers, improve diagnostic accuracy. Key players include commercial service providers, hematology providers, and government reference laboratories. Blood donation centers and blood banks also contribute significantly to the market. Hemorrhagic conditions, infection-related conditions, anemia, leukemia, and other blood disorders are primary applications. The adoption rate is high due to the growing healthcare sector and increasing prevalence of blood disorders.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!